This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

This coming Thursday was supposed to be the deadline for federal health systems to show the patient care decision-making ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Earlier this month, the FDA delayed a decision on whether to grant full approval to Novavax’s Covid-19 vaccine, and over the ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

STAT senior writer Helen Branswell reflects on the trajectory of the Covid-19 pandemic: about the wishful thinking that led ...

In today's Morning Rounds newsletter, HHS axes an autism registry, the Trump presidency approaches 100 days, and funding for ...